BLACKSBURG, Va., March 10, 2022 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral…
WARRINGTON, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused…
Innovative new robotic targeting and navigation system provides precision, accessibilityPALM BEACH GARDENS, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- Accelus,…
REDWOOD CITY, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic…
CAMBRIDGE, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel…
Harnessing Artificial Intelligence, Eyenuk is Focused on Improving Population Health Outcomes by Bringing Diabetes Complication Management to Point-of-Care and Community…
DUBLIN, Ireland and CHICAGO, March 10, 2022 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical…
Vaughan, Ontario--(Newsfile Corp. - March 10, 2022) - Delota Corp. (TSXV: LOTA) ("Delota" or the "Company"), an established Canadian cannabis…
Kick-starter capital targets small and mid-market companies as increased focus is put on Scope 3 CO2 emissions Small and medium…
SAN FRANCISCO--(BUSINESS WIRE)--Tempo Automation (“Tempo”), a leading software-accelerated electronics manufacturer, today announced that Joy Weiss, Tempo’s Chief Executive Officer, and…